Page last updated: 2024-11-13

3-fluoromethcathinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-fluoromethcathinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID53415330
SCHEMBL ID14655814
MeSH IDM0573075

Synonyms (21)

Synonym
3'-fluoromethcathinone
78p68l3b0h ,
3-flephedrone
1049677-77-1
3-fmc
3-fluoromethcathinone
unii-78p68l3b0h
dea no. 1233
AKOS006309763
PQIBROLLUQSNQI-UHFFFAOYSA-N
J2.929.934J ,
SCHEMBL14655814
1-propanone, 1-(3-fluorophenyl)-2-(methylamino)-
3-fluoro-n-methylcathinone
1-(3-fluorophenyl)-2-(methylamino)propan-1-one
Q4634142
DTXSID201017048
2-(methylamino)-1-(3-fluorophenyl)-1-propanone
(s)-3-fluoromethcathinone
Q27266683
PD046870
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (90.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.80 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index61.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]